Home・Elenco Azioni・AngioDynamics Inc

AngioDynamics Inc

Chiusa

SettoreSettore sanitario

15.75 0.7

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

15.59

Massimo

15.71

Metriche Chiave
By Trading Economics
Entrata	-3.3M -11M
Vendite	8.2M 87M
EPS	-0.07
Margine di Profitto	-13.169
Dipendenti	632
EBITDA	-26M -28M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+33.84% upside

Dividendi
By Acuity
Utili prossimi	1 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	99M 627M
Apertura precedente	15.05
Chiusura precedente	15.75

Notizie sul Sentiment di mercato

By Acuity

50%

116 / 340 Classifica in Healthcare

AngioDynamics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6 ago 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5 ago 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4 ago 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3 ago 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 lug 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 lug 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 lug 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 lug 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 lug 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 lug 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 lug 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 lug 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 lug 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 lug 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Confronto tra pari

Modifica del prezzo

AngioDynamics Inc Previsione

Obiettivo di Prezzo

By TipRanks

33.84% in crescita

Previsioni per 12 mesi

Media 21 USD 33.84%

Alto 24 USD

Basso 19 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per AngioDynamics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a AngioDynamics Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

116 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.